pharmaphorum

NOVEMBER 17, 2020

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. The webinar will also cover: Building better relationships between pharma/CROs and patient advocates.

Documentation 116

Documentation Pharmaceutical Companies Pharmaceutical Companies Hospitals 116

pharmaphorum

OCTOBER 27, 2022

The concept of patient centricity has been a key talking point across the healthcare ecosystem for years. Having recognised the tangible benefits that their unique insights and experiences can bring to the table, decision-makers are increasingly seeking new opportunities to partner with patients across a product’s lifecycle.

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies 103

Express Pharma

AUGUST 30, 2023

The visit followed the G20 Health Ministers’ meeting in Gandhinagar, India on August 18 and 19, where health ministers from around the world met to discuss global health issues. Across our large and diversified product portfolio, we provide key therapies to meet the needs of patients.

Pharmaceutical Companies 94

Pharmaceutical Companies Pharmaceutical Companies 94

Pharmacy Times

JULY 10, 2023

When a patient is engaged in the home by a team that includes a pharmacist resource, social determinants of health issues become more clear and the care team can help close the gaps.

49

49

Putting Patients First Blog

JANUARY 22, 2024

NHC’s Response to Bill Cassidy Gene Therapy RFI (PDF) January 22, 2024 The Honorable Bill Cassidy Ranking Member Committee on Health, Education, Labor, and Pensions United States Senate Washington, DC, 20510 Dear Ranking Member Cassidy: The National Health Council (NHC) appreciates your work in exploring issues affecting access to gene therapies.

40

40

Express Pharma

MAY 6, 2024

Chakravarthi AVPS, Global Ambassador from World Packaging Organisation, emphasised “patient centricity” — designing packaging that is inclusive, engaging and informative, essentially making the package a “second physician” for the patient, especially in a post- pandemic world.

Packaging 100

Packaging Pharmaceutical Manufacturing Labelling Pharmaceutical Companies 100

FDA Law Blog: Biosimilars

MAY 13, 2024

FDA recognizes the potential of RWE to support regulatory submissions of medical devices and to inform benefit-risk analysis of such products, while assuring patients have timely access to devices. However, in our experience, there is a large gap between FDA’s lauding the value of RWE and practice.

Medical Records 111

Medical Records Documentation 111

pharmaphorum

JUNE 1, 2022

Using just a headset, the user can be placed into a learning environment where they can perform tasks safely without risk, or they can be provided with a more engaging learning environment. The training challenge. Research found that healthcare CEOs identified the availability of skilled staff as one of their top five key risks.

Vaccines 145

Vaccines Immunity Immunization Hospitals 145

Board Vitals - Pharmacist

NOVEMBER 15, 2023

Clinical Psychiatry Development and Maturation across the Lifespan (30 Items) Physical, Cognitive, Social, Sexual, and others Behavioral and Social Sciences (15 Items) Psychology Behavioral/Cognitive psychology Neuropsychology/Learning theory Psychoanalytic/Psychodynamic theory Social psychology/Sociology/Anthropology/Ethnology Other behavioral/social (..)

98

98

Putting Patients First Blog

JANUARY 11, 2024

The PEMT was created to better capture patient experience data more holistically, helping researchers engage and document patients’ experiences before a diagnosis, post diagnosis, while living with and during treatment of a chronic disease. In the U.S.,

Mayo Clinic 111

Mayo Clinic Documentation 111

Outsourcing Pharma

AUGUST 18, 2020

A leader from the clinical trial patient engagement specialist discusses how clinical trial teams can tackle tricky travel issues in the face of the pandemic.

74

74

Putting Patients First Blog

SEPTEMBER 21, 2023

CMS Federal-State Coordination John Hammarlund, Deputy Director for Local Engagement and Administration at CMS Office of Program Operations and Local Engagement (OPOLE), opened the Roundtable with an overview of OPOLE’s mission and organizational structure.

Drug Pricing 52

Drug Pricing 52

PharmaState Academy

FEBRUARY 29, 2024

CASE STUDY Adapting Sales Strategies for Remote Engagement in the Pharmaceutical Industry Table of Contents Case Study Context and Background: The pharmaceutical industry is undergoing a transformative shift in its sales approaches, propelled by technological advancements and changing healthcare dynamics. And what about my patients?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed. Medicines manufacturing is energy intensive.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Vaccines 97

pharmaphorum

APRIL 6, 2022

Ensuring that patients remain consistent with their therapies is one of the major challenges facing healthcare, so what if you could make treatment a game? Due to this, there has been a growth of interest in using this potential for engagement to develop game-based therapeutics. Adding a unique clinical tool.

111

111

Putting Patients First Blog

FEBRUARY 5, 2024

A Reminder of NHC Benefits February 5, 2024 By: Bob Scott, Director, Member Services The National Health Council (NHC) brings diverse organizations together to forge consensus, drive patient-centered health policy, and provide a united voice for the more than 160 million people with chronic diseases and disabilities and their family caregivers.

Documentation 59

Documentation Communication 59

PharmaState Academy

APRIL 6, 2024

CASE STUDY Effective Customer Communication - Launching a New Drug in Rural India Table of Contents Case Study Introduction: As the leader of the marketing team at ABCG Pharmaceuticals, you oversee the launch of a groundbreaking new drug designed to address a prevalent health issue in rural India.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharmacy Times

NOVEMBER 1, 2023

Experts discuss best practices for improving patient adherence to hemophilia A therapies, including addressing adherence issues and patient engagement.

26

26

pharmaphorum

DECEMBER 15, 2021

In the pharma industry, “patient engagement” and “patient centricity” might seem like interchangeable bits of corporate jargon. Going from the vital activity of patient engagement to the more encompassing state of patient centricity requires big steps in the evolution of new-drug discovery, development, and delivery.

Drug Development 143

Drug Development Communication Hospitals 143

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Involving patients in discussions.

Communication 91

Communication Documentation Hospitals Vaccines 91

Putting Patients First Blog

MARCH 15, 2024

House of Representatives Washington, DC 20515 Dear Chairwoman Foxx: On behalf of the National Health Council (NHC), we appreciate your attention to the important issue of employer-sponsored health benefits, which are governed by the Employee Retirement Income Security Act (ERISA).

Insurance Coverage and Processing 40

Insurance Coverage and Processing 40

Express Pharma

AUGUST 11, 2023

Pioneering science is accelerating our understanding of disease, helping us better predict clinical success, develop and deliver life changing medicines and increase engagement in the clinic and beyond. India is unique and presents exciting opportunities. AstraZeneca continues to place a high priority on cancer.

Communication 96

Communication Diabetes 96

Express Pharma

AUGUST 10, 2023

While it initially focused on improving patient access to trials, they are now recognised for their immense potential to enhance the efficiency and effectiveness of the entire clinical trial process. How has the role of decentralised clinical trials (DCTs) evolved in the clinical research industry?

Communication 89

Communication 89

Pharmaceutical Business Review

SEPTEMBER 11, 2023

An engineered interleukin-2 (IL-2)-diphtheria toxin fusion protein, Lymphir is intended for relapsed or refractory CTCL patients following treatment with a minimum of one systemic therapy previously. Citius Pharmaceuticals chairman and CEO Leonard Mazur said: “We are encouraged by the constructive engagement with the FDA.

52

52

Putting Patients First Blog

JUNE 8, 2023

The NHC Hosts Inaugural International Patient Forum June 8, 2023 By Jennifer Schleman, SVP Communications & Governance On Wednesday, May 31, the National Health Council (NHC) hosted its Inaugural International Patient Forum. and abroad is valuable and doable, and, that patient groups are open to sharing best practices.

Communication 52

Communication 52

pharmaphorum

DECEMBER 14, 2020

As this issue’s title suggests, patient centricity is about more than just talking points and marketing strategies – it requires companies to truly listen to, engage with and partner with the patients they serve, and in putting this month’s Deep Dive together it’s been great to see that so many pharma firms are now taking this to heart.

Pharmaceutical Companies 70

Pharmaceutical Companies Pharmaceutical Companies 70

Putting Patients First Blog

AUGUST 28, 2023

Made up of more than 150 national health- related organizations and businesses, the NHC’s core membership includes the nation’s leading patient organizations. Without coverage, advances in technology will not benefit patients. The NHC supports efforts to get emerging technology to patients as efficiently and safely as possible.

40

40

pharmaphorum

DECEMBER 15, 2022

With millions of HCPs using social media on a regular basis worldwide, engaging with them on one of these platforms should be a no-brainer. Still, many pharma and medical marketers have been reluctant to engage with HCPs on social media. Rather, they aim to educate and engage their followers. Healthcare Provider (HCP) marketing.

Communication 95

Communication Vaccines 95

pharmaphorum

DECEMBER 2, 2022

Read on for key stories from this year’s Frontiers Health conference in Italy, unlocking the promise of patient support programmes in oncology, supercharging communications with modular content, and much more. Unlocking the promise of patient support programmes in oncology. A history of medical imaging. Company profile: Vinehealth.

Communication 52

Communication Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

OCTOBER 18, 2022

Now that the COVID-19 pandemic has provided the industry with a solid foundation of experience with decentralised trials, it is appropriate to reflect and ask whether DCT studies are truly helping to address long-standing issues in research and development for sponsors, study teams and, most importantly, patients.

Drug Development 95

Drug Development Communication Vaccines 95

pharmaphorum

OCTOBER 28, 2021

As the world is slowly, gradually, hopefully emerges from the shadow of COVID-19 there’s a unique opportunity to re-discover what matters most to patients. Time for a new model in patient access. We now have a unique opportunity to re-discover what matters most to patients, says Alnylam’s Kasha Witkos.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

pharmaphorum

SEPTEMBER 21, 2021

Global Gene’s Craig Martin introduces a new patient identification initiative that strives to improve diagnosis and access to clinical trials for all patients with rare CNS conditions. The average diagnostic odyssey for a rare disease patient is about 5-7 years. Understanding the needs of underserved patients.

Communication 74

Communication Drug Development 74

Digital Pharmacist

JULY 11, 2023

By diversifying services and embracing a patient-centered approach, independent pharmacies can position themselves as vital healthcare hubs within their communities. One effective strategy to achieve this is by offering top-notch clinical services that not only enhance patient care but also contribute to a significant revenue boost.

Independent Pharmacies 98

Independent Pharmacies Medication Therapy Management (MTM) Compounding Scheduling Appointments 98

PharmaState Academy

MARCH 8, 2024

This case study delves into strategies for adapting communication styles to engage with each stakeholder group and promote effective collaboration in healthcare settings. Scenario: In the bustling environment of pharmaceutical sales, your seasoned representative finds themselves at the forefront of a pivotal moment.

Communication 52

Communication Documentation Hospitals 52

PharmaState Academy

MARCH 6, 2024

This case study delves into strategies for adapting communication styles to engage with each stakeholder group and promote effective collaboration in healthcare settings. Scenario: In the bustling environment of pharmaceutical sales, your seasoned representative finds themselves at the forefront of a pivotal moment.

Communication 52

Communication Documentation Hospitals 52

pharmaphorum

SEPTEMBER 22, 2022

Cut off from tried and tested methods of engaging with stakeholders, digital, and virtual solutions were thrust into the limelight as the industry proactively accelerated the adoption of technology across all levels of healthcare. Next generation patient engagement and enriched insights. Subscribe to future issues of Deep Dive.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

Putting Patients First Blog

FEBRUARY 8, 2024

This is an issue of great importance to patients and the patient community. The NHC recognizes that this hearing focuses on both the potential benefits and risks of artificial intelligence (AI) for patients, as the patient community is also acutely focused on this duality.

40

40